C2C vs TIRUPATIFL: Stock Comparison

C2C vs TIRUPATIFLUpdated 23 Jul 26, 4:08 PM ISTNSE & company filings

TIRUPATIFL is the larger company by market capitalisation. C2C shows a lower P/E, a higher ROE and faster revenue growth, while TIRUPATIFL shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

C2C leads 10; TIRUPATIFL leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

C2CTIRUPATIFL

Valuation lens

What price are you paying?

Market CapContext only
₹346 Cr
₹880 Cr
P/E RatioC2C has the lower reading
0x
144.08x
P/B RatioC2C has the lower reading
0x
6.7x
EPSC2C has the higher reading
₹10.8
₹0.09
Book ValueContext only
₹139.36
₹10.33
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
TIRUPATIFL is the larger company
₹880 Cr vs ₹346 Cr
P/E Ratio
C2C has a lower P/E
0x vs 144.08x
P/B Ratio
C2C has a lower P/B
0x vs 6.7x
EPS
C2C has higher earnings per share
₹10.8 vs ₹0.09
Revenue Growth (TTM YoY)
C2C has faster revenue growth
0% vs -4%
EPS Growth (TTM YoY)
C2C has faster EPS growth
0% vs -39.53%
Qtr Sales Growth
C2C has stronger quarterly sales growth
120.35% vs -9.09%
Qtr Profit Growth
TIRUPATIFL has stronger quarterly profit growth
-19.91% vs -22.51%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricC2CTIRUPATIFL
SectorCapital Goods
IndustryCastings & Forgings

Price

MetricC2CTIRUPATIFL
Live Price₹77.48
Day Change-4.99%
Volume13.45 L
52-Week High₹83.9
52-Week Low₹30.11
Distance from 52W High-7.65%

Valuation

MetricC2CTIRUPATIFL
Market Cap₹346 Cr₹880 Cr
P/E Ratio0x144.08x
P/B Ratio0x6.7x
EPS₹10.8₹0.09
Book Value₹139.36₹10.33
Dividend Yield0%0%

Growth

MetricC2CTIRUPATIFL
Revenue Growth (TTM YoY)0%-4%
EPS Growth (TTM YoY)0%-39.53%
Qtr Sales Growth120.35%-9.09%
Qtr Profit Growth-22.51%-19.91%

Profitability & Leverage

MetricC2CTIRUPATIFL
ROE47.89%4.72%
ROCE41.23%5.28%
Net Margin0%3.87%
Operating Margin44.99%7.14%
Debt to Equity0.19x0.26x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricC2CTIRUPATIFL
Promoter Holding36.98% 4.31 pp49.42% 0.33 pp
FII Holding3.18% 1.24 pp0.76% 0.31 pp
DII Holding0.1% 1.77 pp0%
Public Holding59.75% 4.85 pp49.82% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: C2C and TIRUPATIFL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.